title: Early Insights from Commercialization of Gene Therapies in Europe.
abstract: After years of research and development, gene therapies are now becoming a commercial reality with several products approved by European regulatory authorities [...].
authors.affiliation: Strategy Consulting, London SW15 2AW, UK. nicolas.touchot@groupH.com.
authors.forename: Nicolas
authors.initials: N
authors.lastname: Touchot
authors.affiliation: Kassenärztliche Vereinigung Westfalen Lippe, Dortmund 44141, Germany. mathias.flume@gmx.de.
authors.forename: Mathias
authors.initials: M
authors.lastname: Flume
keywords: Glybera; Imlygic; Strimvelis; commercialization; gene therapies; market access; payers; reimbursement